title: Promotion of attachment of human bone marrow stromal cells by CCN2.
abstract: Cell attachment is a crucial step in tissue regeneration. In this study, human bone marrow stromal cells (hBMSCs) were isolated, and the effects of CCN2 on their attachment were examined. CCN2 significantly enhanced the hBMSC attachment, and this enhanced cell attachment was mainly regulated by the C-terminal module of CCN2. This enhancement was negated by the anti-integrin alpha(v)beta(3) antibody and p38 MAPK inhibitor, and phosphorylation of p38 MAPK was detected upon the enhanced cell attachment mediated by CCN2. We thus conclude that CCN2 enhances hBMSC attachment via integrin-p38 MAPK signal pathway. Enhanced hBMSC attachment on hydroxyapatite plates by CCN2 further indicated the utility of CCN2 in bone regeneration.
authors.affiliation: Department of Oral and Maxillofacial Rehabilitation, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama 700-8525, Japan.
authors.forename: Mitsuaki
authors.initials: M
authors.lastname: Ono
authors.forename: Satoshi
authors.initials: S
authors.lastname: Kubota
authors.forename: Takuo
authors.initials: T
authors.lastname: Fujisawa
authors.forename: Wataru
authors.initials: W
authors.lastname: Sonoyama
authors.forename: Harumi
authors.initials: H
authors.lastname: Kawaki
authors.forename: Kentaro
authors.initials: K
authors.lastname: Akiyama
authors.forename: Masamitsu
authors.initials: M
authors.lastname: Oshima
authors.forename: Takashi
authors.initials: T
authors.lastname: Nishida
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Yoshida
authors.forename: Kazuomi
authors.initials: K
authors.lastname: Suzuki
authors.forename: Masaharu
authors.initials: M
authors.lastname: Takigawa
authors.forename: Takuo
authors.initials: T
authors.lastname: Kuboki
mesh_terms: D001854:Bone Marrow Cells / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D018786:Bone Substitutes / Q000737:chemistry; D002448:Cell Adhesion / Q000187:drug effects; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D002478:Cells, Cultured; D055513:Connective Tissue Growth Factor; D004305:Dose-Response Relationship, Drug; D017886:Durapatite / Q000737:chemistry; D006801:Humans; D017874:Immediate-Early Proteins / Q000008:administration & dosage*; D036341:Intercellular Signaling Peptides and Proteins / Q000008:administration & dosage*; D059630:Mesenchymal Stem Cells / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D010006:Osteoblasts / Q000166:cytology* / Q000187:drug effects / Q000502:physiology*; D010012:Osteogenesis / Q000187:drug effects*; D017154:Stromal Cells / Q000166:cytology / Q000187:drug effects / Q000502:physiology; D023822:Tissue Engineering / Q000379:methods*
chemical_list: D018786:Bone Substitutes; C526317:CCN2 protein, human; D017874:Immediate-Early Proteins; D036341:Intercellular Signaling Peptides and Proteins; D055513:Connective Tissue Growth Factor; D017886:Durapatite